Trial Profile
Non-interventional Study to Investigate Efficacy and Safety of Trabectedin (Yondelis) in Patients With Advanced Soft Tissue Sarcoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms YonSar
- Sponsors PharmaMar
- 13 Sep 2022 Status changed from recruiting to completed, according to Results presented at the 47th European Society for Medical Oncology Congress.
- 13 Sep 2022 Results presented at the 47th European Society for Medical Oncology Congress
- 14 Nov 2018 Planned End Date changed from 1 Jan 2018 to 1 Dec 2020.